Virtual Reality Cognitive Remediation for Psychosis

N/A

Recruiting

Led By Synthia Guimond, PhD

Research Sponsored by The Royal Ottawa Mental Health Centre

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up participants complete the subjective scale to investigate cognition in schizophrenia - brief at baseline, 1-week post-intervention, 3-months post-intervention, and 6-months post-intervention.

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a cognitive intervention using virtual reality to help people living with psychotic disorders better manage their thinking and social skills to improve day-to-day life.

Who is the study for?

This trial is for people aged 20-55 with a psychosis-spectrum disorder like schizophrenia, who speak English and have had stable medication doses for the past month. It's not suitable for those with cognitive impairments from other conditions, no smartphone, seizure history, severe eye/ear/balance issues, significant brain injury, intellectual disability or recent substance abuse.

What is being tested?

The study tests a virtual reality program designed to improve thinking and social skills in individuals with psychotic disorders. Participants will use VR as part of cognitive remediation therapy to see if it helps them better manage daily activities and relationships.

What are the potential side effects?

While not explicitly listed here, potential side effects may include discomfort or dizziness due to VR usage; however these are generally mild and can be managed by adjusting the duration of VR sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ participants complete the subjective scale to investigate cognition in schizophrenia - brief at baseline, 1-week post-intervention, 3-months post-intervention, and 6-months post-intervention.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~participants complete the subjective scale to investigate cognition in schizophrenia - brief at baseline, 1-week post-intervention, 3-months post-intervention, and 6-months post-intervention.

This trial's timeline: 3 weeks for screening, Varies for treatment, and participants complete the subjective scale to investigate cognition in schizophrenia - brief at baseline, 1-week post-intervention, 3-months post-intervention, and 6-months post-intervention. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of the intervention

Change in neurocognitive performance from baseline to 1-week and 3-months post- intervention (Cambridge Automated Neuropsychology Battery).

Change in social cognition performance from baseline to 1-week and 3-months post-intervention (Ambiguous Intentions Hostility Questionnaire).

+10 more

Secondary study objectives

Change in the EMA Community Functioning performance from baseline to 1-week and 6-months post-intervention ( Questionnaire about Process to Recovery).

Change in the EMA Community Functioning performance from baseline to 1-week and 6-months post-intervention (Social Functioning Questionnaire).

Change in the EMA Neurocognition performance from baseline to 1-week and 6-months post-intervention - Jewel task

+1 more

Other study objectives

Affect

Change in Self-Reported Neurocognition performance from baseline to 1-week, 3-months and 6-months post intervention- Subjective Scale to Investigate Cognition in Schizophrenia - Brief.

Change in Symptom Severity from baseline to 1-week post-intervention and 3-months post-intervention.

+8 more